[HTML][HTML] Application of monoclonal antibody drugs in treatment of COVID-19: a review

A Kirillova, A Lado, N Blatt - Bionanoscience, 2022 - Springer
Coronavirus infection can have various degrees of severity and outcomes. In some cases, it
causes excessive production of pro-inflammatory cytokines, a so-called cytokine storm …

[HTML][HTML] Update on immunology of COVID-19 disease and potential strategy for controlling

NK Dezfuli, IM Adcock, N Montazami, E Mortaz… - Tanaffos, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is caused by a novel form of the coronavirus
that caused severe acute respiratory syndrome (SARS). SARS-CoV-2 raised in China and …

Therapeutics for the management of cytokine release syndrome in COVID-19

S Ghosh, S Durgvanshi, SS Han… - Current topics in …, 2023 - ingentaconnect.com
Coronavirus disease (COVID-19) is the greatest pandemic of this era and has affected more
than 10 million people across 213 nations. However, the etiology, management, and …

[HTML][HTML] Molecular immune pathogenesis and diagnosis of COVID-19

X Li, M Geng, Y Peng, L Meng, S Lu - Journal of pharmaceutical analysis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …

[HTML][HTML] Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens

A Tanveer, B Akhtar, A Sharif, U Saleem, A Rasul… - …, 2022 - Springer
The Covid-19, a threatening pandemic, was originated from China in December 2019 and
spread quickly to all over the world. The pathogenesis of coronavirus is linked with the …

[HTML][HTML] Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19)

C Datta, A Bhattacharjee - Journal of …, 2020 - immunologyresearchjournal.com
Abstract Corona virus disease 2019 (COVID-19), is a viral disease caused by novel corona
virus known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The …

[HTML][HTML] Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19

FH Pottoo, T Abu-Izneid, AM Ibrahim, MN Javed… - Saudi pharmaceutical …, 2021 - Elsevier
Coronaviruses are non-segmented and single stranded positive-sense RNA (+ ssRNA)
viruses. To date, 06 human coronaviruses (HCoVs) are reported; α-CoVs (HCoVs-NL63 and …

[HTML][HTML] Cytokine storm and immunomodulation in COVID-19

P Rangappa - Indian Journal of Critical Care Medicine: Peer …, 2021 - ncbi.nlm.nih.gov
ABSTRACT COVID-19 has become a major pandemic in recent times. The exact
pathophysiology and understanding of cytokine storm and immunomodulation are evolving …

[HTML][HTML] Calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19

AE Peter, BV Sandeep, BG Rao… - Frontiers in …, 2021 - frontiersin.org
The COVID-19 pandemic has caused a global health crisis, with no specific antiviral to treat
the infection and the absence of a suitable vaccine to prevent it. While some individuals …

[PDF][PDF] Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …